Mazen A. Ghanem

558 total citations
24 papers, 375 citations indexed

About

Mazen A. Ghanem is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mazen A. Ghanem has authored 24 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Mazen A. Ghanem's work include Renal and related cancers (9 papers), Renal cell carcinoma treatment (5 papers) and Pediatric Urology and Nephrology Studies (5 papers). Mazen A. Ghanem is often cited by papers focused on Renal and related cancers (9 papers), Renal cell carcinoma treatment (5 papers) and Pediatric Urology and Nephrology Studies (5 papers). Mazen A. Ghanem collaborates with scholars based in Egypt, Netherlands and Saudi Arabia. Mazen A. Ghanem's co-authors include Rien J.M. Nijman, Theodorus van der Kwast, G.J. van Steenbrugge, Katja P. Wolffenbuttel, Marinus A. Noordzij, Jan C. den Hollander, Rejiv B. Mathoera, M.H.A. Oomen, Gert R. Dohle and Andrew M. Scott and has published in prestigious journals such as Cancer, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Mazen A. Ghanem

22 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mazen A. Ghanem Egypt 11 200 140 103 72 52 24 375
Mona S. Jahromi United States 10 84 0.4× 78 0.6× 50 0.5× 38 0.5× 20 0.4× 13 259
Borislav Spajić Croatia 10 95 0.5× 157 1.1× 51 0.5× 33 0.5× 73 1.4× 44 297
Angelo Cambio United States 9 119 0.6× 213 1.5× 105 1.0× 46 0.6× 95 1.8× 15 391
Haruhito Kikuchi Japan 11 159 0.8× 158 1.1× 17 0.2× 28 0.4× 40 0.8× 20 356
Jonathan E. Wickiser United States 11 290 1.4× 198 1.4× 25 0.2× 76 1.1× 141 2.7× 18 420
Trevor Dorkin United Kingdom 14 194 1.0× 135 1.0× 163 1.6× 11 0.2× 133 2.6× 24 459
Sierra Li United States 5 492 2.5× 285 2.0× 42 0.4× 120 1.7× 32 0.6× 5 576
D. Rosell Spain 12 87 0.4× 225 1.6× 34 0.3× 18 0.3× 174 3.3× 50 401
Hiroko Gotoda Japan 10 80 0.4× 259 1.9× 13 0.1× 42 0.6× 75 1.4× 22 352
Patrick Melchior Germany 9 147 0.7× 109 0.8× 11 0.1× 40 0.6× 24 0.5× 36 279

Countries citing papers authored by Mazen A. Ghanem

Since Specialization
Citations

This map shows the geographic impact of Mazen A. Ghanem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazen A. Ghanem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazen A. Ghanem more than expected).

Fields of papers citing papers by Mazen A. Ghanem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mazen A. Ghanem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazen A. Ghanem. The network helps show where Mazen A. Ghanem may publish in the future.

Co-authorship network of co-authors of Mazen A. Ghanem

This figure shows the co-authorship network connecting the top 25 collaborators of Mazen A. Ghanem. A scholar is included among the top collaborators of Mazen A. Ghanem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazen A. Ghanem. Mazen A. Ghanem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghalwash, Dalia, et al.. (2024). Epidemiology of Sjogren’s syndrome in a sample of the Egyptian population: a cross-sectional study. Journal of International Medical Research. 52(10). 3649350220–3649350220. 6 indexed citations
2.
Ghanem, Mazen A., et al.. (2024). Long-term outcomes of erectile function in adult orchidopexy patients. Asian journal of urology. 11(4). 642–650.
3.
Ghanem, Mazen A., et al.. (2022). Platelet volume parameters as a tool in the evaluation of acute ischemic priapism in patients with sickle cell anemia. Archivio Italiano di Urologia e Andrologia. 94(2). 217–221.
4.
Ghanem, Mazen A., et al.. (2022). High platelet distribution width can independently predict testicular survival in testicular torsion among patients with steady-state sickle cell anemia. World Journal of Pediatric Surgery. 5(1). e000358–e000358. 2 indexed citations
5.
Ghanem, Mazen A., et al.. (2020). The impact of adenotonsillectomy on monosymptomatic primary nocturnal enuresis in children with obstructive sleep apnea syndrome. Journal of Clinical Urology. 14(6). 447–453. 2 indexed citations
6.
7.
Ghanem, Mazen A., et al.. (2018). Double Intravesical Migration of Intrauterine Devices: Presented With Vesical Stone Formation. 7(2). 60–62. 2 indexed citations
10.
Ghanem, Mazen A., et al.. (2011). The role of varicocele sclerotherapy in men with severe oligo-astheno-teratozoospermia. Asian Journal of Andrology. 13(6). 867–871. 8 indexed citations
11.
Ghanem, Mazen A., et al.. (2011). The predictive value of immunohistochemical markers in untreated Wilms’ tumour: are they useful?. World Journal of Urology. 31(4). 811–816. 7 indexed citations
12.
Ghanem, Mazen A. & Rien J.M. Nijman. (2010). Outcome analysis of tubularized incised urethral plate using dorsal dartos flap for proximal penile hypospadias repair. Journal of Pediatric Urology. 6(5). 477–480. 14 indexed citations
13.
Ghanem, Mazen A., et al.. (2010). Expression and prognostic value of platelet‐derived growth factor‐AA and its receptor α in nephroblastoma. British Journal of Urology. 106(9). 1389–1393. 14 indexed citations
14.
Ghanem, Mazen A., Rebecca Herbertson, Salvatore U. Berlangieri, et al.. (2009). Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma. Molecular Imaging and Biology. 11(6). 473–479. 24 indexed citations
15.
Ghanem, Mazen A., G.J. van Steenbrugge, Rien J.M. Nijman, & Theodorus van der Kwast. (2005). Prognostic markers in nephroblastoma (Wilms’ tumor). Urology. 65(6). 1047–1054. 20 indexed citations
16.
Ghanem, Mazen A., et al.. (2004). MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma. Clinical Cancer Research. 10(2). 591–597. 24 indexed citations
17.
Ghanem, Mazen A., et al.. (2003). Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. Journal of Clinical Pathology. 56(2). 107–113. 59 indexed citations
18.
Ghanem, Mazen A., et al.. (2002). Expression And Prognostic Value Of CD44 Isoforms In Nephroblastoma (Wilms Tumor). The Journal of Urology. 168(2). 681–686. 9 indexed citations
19.
Ghanem, Mazen A., Theodorus van der Kwast, Jan C. den Hollander, et al.. (2001). Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-?, and c-erb B-2 in nephroblastoma. Cancer. 92(12). 3120–3129. 36 indexed citations
20.
Ghanem, Mazen A., Theodorus van der Kwast, Jan C. den Hollander, et al.. (2000). Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.. PubMed. 6(11). 4265–71. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026